journal article·2023-12-31Open access

The Rhei radix rhizoma-based carbon dots ameliorates dextran sodium sulphate-induced ulcerative colitis in mice

Yifan Zhang, Jie Zhao, Yusheng Zhao, Xue Bai, Yumin Chen, Yuhan Liu, Yue Zhang, Hui Kong, Huihua Qu, Yan Zhao

Abstract

As an autoimmune disease of the colon, the incidence of ulcerative colitis (UC) remains high. Carbon dots (CDs), a new type of nanomaterials, display excellent biological activity and are expected to inspire a new treatment for UC. A green method was used to carbonise rhei radix rhizoma (RRR) and extract CDs to study their anti-ulcer activity. The RRR-based carbon dots (RRR-CDs) were characterised by electron microscopy, optical techniques, and other techniques. The results indicated RRR-CDs have abundant chemical groups, excellent solubility and tiny size (1.374 nm–4.533 nm), which may be conducive to the exertion of inherent activity. Using a classic dextran sodium sulphate (DSS)-induced UC mouse model, for the first time, it was demonstrated RRR-CDs have significant anti-ulcerative activity in improving DAI score (from 2.8 to 1.6), colon length (4.15 to 6.08), and histopathology in mice. The underlying mechanisms of anti-ulcerative activity may be related to haemostatic, antioxidant, and anti-inflammatory activities to protect the mucosal barrier. RRR-CDs have symptomatic and potential mechanisms of treatment and are expected to become a candidate drug for the treatment of UC. This not only further expands the basis for the biological activity of CDs, but provides a potential treatment plan for solving thorny diseases in clinical practice.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Carbon and Quantum Dots Applications · Advanced Nanomaterials in Catalysis · Selenium in Biological Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People’s Republic of China

School of Life Sciences, Beijing University of Chinese Medicine, Beijing, People’s Republic of China

Center of Scientific Experiment, Beijing University of Chinese Medicine, Chaoyang District, Beijing, People’s Republic of China

Funding

Special Funds for Fundamental Research Funds of institutions of higher learning affiliated with central departments

References (49)

Show source-provided references
1. Wilks S. · London Med Times Gazette · 1859 · 2 · 264
2. 10.1016/j.mayocp.2019.01.01810.1016/j.mayocp.2019.01.018 ↗
3. Hu Y · Front. Pharmacol · 2022 · 13 · 84496110.3389/fphar.2022.844961 ↗
4. Wang J · IJMS · 2019 · 20 · 575110.3390/ijms20225751 ↗
5. 10.1177/096032711989204210.1177/0960327119892042 ↗
6. Kucharzik T · Dtsch Arztebl Int · 2020 · 117 · 564
7. 10.1016/j.msec.2020.11175610.1016/j.msec.2020.111756 ↗
8. 10.1016/j.watres.2018.09.04010.1016/j.watres.2018.09.040 ↗
9. 10.1039/C9NR05647E10.1039/C9NR05647E ↗
10. 10.2174/138161282666620040210230810.2174/1381612826666200402102308 ↗
11. Miao H · Biosens Bioelectron · 2016 · 86 · 8310.1016/j.bios.2016.06.043 ↗
12. 10.1002/cssc.20170184710.1002/cssc.201701847 ↗
13. Nair A · Biomed Pharmacother · 2020 · 132 · 11083410.1016/j.biopha.2020.110834 ↗
14. 10.1016/j.bios.2015.12.08710.1016/j.bios.2015.12.087 ↗
15. 10.1016/j.bios.2019.02.05910.1016/j.bios.2019.02.059 ↗
16. Bharathi D · J Fluoresc · 2018 · 28 · 57310.1007/s10895-018-2218-3 ↗
17. Zhou Y · Sci. Adv · 2020 · 6 · 703110.1126/sciadv.abc7031 ↗
18. Pei J · Biomater Sci · 2020 · 8 · 642810.1039/D0BM01447H ↗
19. Zhang M · J Nanobiotechnology · 2021 · 19 · 10510.1186/s12951-021-00847-y ↗
20. Zhao Y · Int J Nanomedicine · 2022 · 17 · 110.2147/IJN.S338886 ↗
21. 10.2217/nnm-2017-029710.2217/nnm-2017-0297 ↗
22. 10.1166/jbn.2018.261310.1166/jbn.2018.2613 ↗
23. Gao C · Theranostics · 2022 · 12 · 559610.7150/thno.73650 ↗
24. 10.1016/j.jep.2020.11295610.1016/j.jep.2020.112956 ↗
25. Huang JQ · Front Cell Infect Microbiol · 2022 · 12 · 90781310.3389/fcimb.2022.907813 ↗
26. Hidalgo-Garcia L · Acta Physiol · 2021 · 233 · e1369910.1111/apha.13699 ↗
27. Yue L · Mikrochim Acta · 2019 · 186 · 31510.1007/s00604-019-3407-8 ↗
28. 10.2217/nnm-2019-036910.2217/nnm-2019-0369 ↗
29. 10.1080/21691401.2019.169981010.1080/21691401.2019.1699810 ↗
30. 10.3390/molecules2503044610.3390/molecules25030446 ↗
31. 10.1016/j.jcis.2021.02.05810.1016/j.jcis.2021.02.058 ↗
32. 10.1016/j.neuint.2021.10500810.1016/j.neuint.2021.105008 ↗
33. Mondal S · J Am Chem Soc · 2019 · 141 · 1541310.1021/jacs.9b08071 ↗
34. 10.3390/molecules2302037810.3390/molecules23020378 ↗
35. 10.1016/j.msec.2020.11065110.1016/j.msec.2020.110651 ↗
36. 10.1016/j.ijpharm.2020.11970110.1016/j.ijpharm.2020.119701 ↗
37. Xu X · ACS Appl Mater Interfaces · 2016 · 8 · 3270610.1021/acsami.6b12252 ↗
38. 10.1039/D1TB01077H10.1039/D1TB01077H ↗
39. 10.1016/j.cis.2019.10204610.1016/j.cis.2019.102046 ↗
40. Xu Y · Adv Mater · 2022 · 34
41. 10.3390/molecules2606151210.3390/molecules26061512 ↗
42. 10.2147/IJN.S28197610.2147/IJN.S281976 ↗
43. 10.1021/acsami.1c2170010.1021/acsami.1c21700 ↗
44. 10.1038/nprot.2014.13910.1038/nprot.2014.139 ↗
45. 10.1016/j.intimp.2019.10588410.1016/j.intimp.2019.105884 ↗
46. 10.1016/j.biopha.2018.01.14210.1016/j.biopha.2018.01.142 ↗
47. 10.1080/00365521.2018.144759710.1080/00365521.2018.1447597 ↗
48. 10.1089/rej.2018.208910.1089/rej.2018.2089 ↗
49. 10.1093/ibd/izz14910.1093/ibd/izz149 ↗